◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocks0-9 › 2697

TH MEDICAL-B (2697) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Devices · DATA UPDATED 2026-08-10

TH MEDICAL-B (2697) operates in the Medical Devices industry and is headquartered in Zhuhai, China. In the fiscal year ended 2025-12-31, 2697 reported CNY 12M in revenue and (CNY 90M) in net income.

Guangdong True Health Medical Technology Development Co., Ltd. engages in in the research and development, manufacture and sale of surgical robots and disposables in the People's Republic of China and Hong Kong.

Interactive charts & full statements →

2697 Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-31
Total RevenueCNY 12MCNY 2M
Gross ProfitCNY 9MCNY 1M
Operating Income (EBIT)(CNY 91M)(CNY 93M)
Net Income(CNY 90M)(CNY 92M)

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

2697 Free Cash Flow History

2697 Balance Sheet History

Balance sheet2025-12-312024-12-31
Total AssetsCNY 281MCNY 155M
Total LiabilitiesCNY 41MCNY 30M

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 2697 viewer.

Other Companies in Medical Devices

← 2696All “0-9” companies2698 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.